Because groundbreaking science is most valuable when it can be translated into products that are available to Texans, a crucial component of CPRIT’s mission is to create and support infrastructure in Texas that accelerates the movement of new cancer drugs, diagnostics, and therapies from the laboratory to the patient. This process is called commercialization. CPRIT takes its commitment to commercialization efforts seriously, dedicating personnel and operational funding to major commercial initiatives like the creation of the Commercialization Review Council and the recruitment of a virtual management company.


2017 Innovations Conference Funding Opportunities Spotlight On
Conference Banner

CPRIT's conference brought together nearly 800 scientists, oncologists, bioscience industry leaders, advocates, entrepreneurs, and public health leaders from across Texas and the nation.

View Conference Session Schedule and Presentations

View Event Coverage

Stay Connected

Follow CPRIT on Twitter. Like us on Facebook. Sign-up for CPRIT’s newsletter.

See More 2017 Conference Coverage

Current Product Development Funding Opportunities
For Fiscal Year 2018*

Please enable JavaScript to view this table.

* Dates are subject to change

View Complete Product Development Funding Opportunities Schedule

Paul Lammers

Mirna Therapeutics' Story

Austin-based Mirna Therapeutics is one of two product development research companies in which CPRIT has equity. Paul Lammers, Mirna’s president and CEO, says the company is conducting clinical trials of synthetic micro-RNA, which occur naturally in human cells and can act as tumor suppressors.